{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:15:59Z","timestamp":1785726959710,"version":"3.56.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.jaad.2006.10.020","type":"journal-article","created":{"date-parts":[[2006,12,5]],"date-time":"2006-12-05T07:11:14Z","timestamp":1165302674000},"page":"848-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors"],"prefix":"10.1016","volume":"56","author":[{"given":"Dorota","family":"Krasowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Szymanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"My\u015bli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.10.020_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1185\/030079902125001353","article-title":"Focus on paroxetine","volume":"19","author":"Green","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaad.2006.10.020_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.amjmed.2005.03.044","article-title":"Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?","volume":"119","author":"Serebruany","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2006.10.020_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00128071-200203050-00005","article-title":"Adverse cutaneous reactions to antidepressants","volume":"3","author":"Warnock","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2006.10.020_bib4","first-page":"59","article-title":"The side effect profile and safety of fluoxetine","volume":"46","author":"Wernicke","year":"1985","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/106002809603000716","article-title":"Bruising associated with the use of fluoxetine","volume":"30","author":"Pai","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2006.10.020_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9343(97)00399-9","article-title":"Spontaneous ecchymoses due to paroxetine administration","volume":"104","author":"Cooper","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2006.10.020_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1176\/appi.ajp.158.3.497","article-title":"Cutaneous vasculitis induced by paroxetine","volume":"158","author":"Morgolese","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1176\/ajp.149.3.412a","article-title":"Bleeding, a side effect of fluoxetine","volume":"149","author":"Aranth","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0002-9343(02)01239-1","article-title":"Severe bleeding associated with use of low molecular weight heparin and selective serotonin reuptake inhibitors","volume":"113","author":"Maistre","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2006.10.020_bib10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1176\/ajp.148.7.949b","article-title":"Fluoxetine and bleeding in obsessive-compulsive disorder","volume":"148","author":"Yaryura-Tobias","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0033-3182(96)71592-X","article-title":"Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors","volume":"37","author":"Skop","year":"1996","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jaad.2006.10.020_bib12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0033-3182(99)71206-5","article-title":"Hematologic side effects of psychotropics","volume":"40","author":"Oyesanmi","year":"1999","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jaad.2006.10.020_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00018-004-4262-1","article-title":"Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection","volume":"62","author":"Maurer-Spurej","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaad.2006.10.020_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1176\/ajp.145.4.425","article-title":"Adverse cutaneous reactions to antidepressants","volume":"145","author":"Warnock","year":"1988","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1192\/S000712500029733X","article-title":"The safety of fluoxetine\u2013an update","volume":"153","author":"Cooper","year":"1988","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib16","first-page":"355","article-title":"Adverse cutaneous reactions associated with fluoxetine strategy for\u00a0reintroduction of this drug in selected patients","volume":"12","author":"Leznof","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jaad.2006.10.020_bib17","first-page":"287","article-title":"Stevens-Johnson syndrome after sertaline","volume":"42","author":"Jan","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2006.10.020_bib18","first-page":"441","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome after fluoxetine","volume":"47","author":"Bodokh","year":"1992","journal-title":"Therapie"},{"key":"10.1016\/j.jaad.2006.10.020_bib19","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1176\/ajp.148.11.1602","article-title":"Serum sickness induced by fluoxetine","volume":"148","author":"Vincent","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0140-6736(93)91852-D","article-title":"Toxic epidermal necrolysis after fluvoxamine","volume":"342","author":"Wolkenstein","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2006.10.020_bib21","first-page":"759","article-title":"Cutaneous adverse effects during selective serotonin inhibitor therapy: 2 cases","volume":"128","author":"Richard","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.10.020_bib22","first-page":"62","article-title":"Secondary dermatologic effects of serotonin reuptake inhibitor antidepressants: hypothesis of cross-reacting allergy; apropos of 2 cases","volume":"24","author":"Beauquier","year":"1998","journal-title":"Encephale"},{"key":"10.1016\/j.jaad.2006.10.020_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1345\/aph.1A262","article-title":"Cross-sensitivity between paroxetine and sertraline","volume":"36","author":"Warnock","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2006.10.020_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4088\/JCP.v57n1007b","article-title":"Paroxetine-induced angioedema and tongue swelling","volume":"57","author":"Mithani","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000051717","article-title":"Acute generalized exanthematous pustulosis with photodistribution pattern induced by sertraline","volume":"203","author":"Th\u00e9denat","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2006.10.020_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00023210-199708040-00005","article-title":"Changes in growth and distribution of hair associated with psychotropic drug use","volume":"8","author":"Rebora","year":"1977","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jaad.2006.10.020_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1176\/ajp.153.4.581","article-title":"Hair loss associated with fluvoxamine use","volume":"153","author":"Parameshwar","year":"1996","journal-title":"Am\u00a0J Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib28","first-page":"246","article-title":"Hair loss associated with paroxetine treatment: a case report","volume":"22","author":"Zalsman","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jaad.2006.10.020_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/070674379103600824","article-title":"Hair loss associated with fluoxetine treatment","volume":"36","author":"Ananth","year":"1991","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib30","first-page":"547","article-title":"Alopecia due to Seroxat","volume":"138","author":"Umansky","year":"2000","journal-title":"Harefuah"},{"key":"10.1016\/j.jaad.2006.10.020_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/106002809202600215","article-title":"Fluoxetine-induced psoriasis","volume":"26","author":"Hemlock","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2006.10.020_bib32","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1176\/appi.ajp.159.12.2113","article-title":"Paroxetine-associated psoriasis","volume":"159","author":"Osborne","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1034\/j.1600-0536.2002.470210_10.x","article-title":"Photosensivity induced by paroxetine","volume":"47","author":"Vilaplana","year":"2002","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2006.10.020_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1023\/A:1008600205032","article-title":"Photosensitivity reaction to fluoxetine and alprazolam","volume":"20","author":"Pazzagli","year":"1998","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.jaad.2006.10.020_bib35","first-page":"486","article-title":"Photosensitivity reaction of fluoxetine","volume":"56","author":"Gaufberg","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1440-0960.1996.tb01002.x","article-title":"Fluvoxamine photosensivity","volume":"37","author":"Gillet-Terver","year":"1996","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2006.10.020_bib37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.0007-0963.2004.05882.x","article-title":"Pruritus induced by interruption of paroxetine therapy","volume":"150","author":"Mazzatenta","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.10.020_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000012386","article-title":"Paroxetine in a case of psychogenic pruritus and neurotic excoriations","volume":"69","author":"Biondi","year":"2000","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.jaad.2006.10.020_bib39","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jpainsymman.2003.05.004","article-title":"Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial","volume":"26","author":"Zylicz","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jaad.2006.10.020_bib40","unstructured":"Schwartz RA, Patterson WM, Bienvenu OJ, Chodynicki MP, Janniger CK. Dysmorphophobia. eMedicine Dermatology [journal serial online]. 2006. Available from: http:\/\/www.emedicine.com\/derm\/topic623.htm. Accessed July 26, 2006."},{"key":"10.1016\/j.jaad.2006.10.020_bib41","first-page":"44","article-title":"Body dysmorphic disorder: more than meets the eye","volume":"13","author":"Thomas","year":"2005","journal-title":"Acta Derm Venerol Croatica"},{"key":"10.1016\/j.jaad.2006.10.020_bib42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archderm.134.3.327","article-title":"Scalp dysthesia","volume":"134","author":"Hoss","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.10.020_bib43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2125.1997.00652.x","article-title":"Non-puerperal lactation associated with antidepressant drug use","volume":"44","author":"Egberts","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2006.10.020_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0025-6196(11)63132-7","article-title":"Reversible galactorrhea and prolactin elevation related to fluoxetine use","volume":"76","author":"Peterson","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2006.10.020_bib45","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0140-6736(93)90377-S","article-title":"Paroxetine and extrapyramidal reactions","volume":"341","author":"Choo","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2006.10.020_bib46","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1192\/bjp.165.6.728","article-title":"Extrapyramidal symptoms with selective serotonin reuptake inhibitors","volume":"165","author":"Arya","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib47","first-page":"26","article-title":"Clinical experience with serotonin reuptake inhibiting antidepressants","volume":"48","author":"Mendel","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib48","first-page":"85","article-title":"Fluoxetine-induced stuttering","volume":"51","author":"Guthrie","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib49","first-page":"316","article-title":"Sertraline-induced stuttering","volume":"55","author":"McCall","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib50","first-page":"432","article-title":"SSRI-associated nocturnal bruxism in four patients","volume":"54","author":"Ellison","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib51","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1177\/106002809603001107","article-title":"Possible paroxetine-induced bruxism","volume":"30","author":"Romanelli","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2006.10.020_bib52","first-page":"273","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine","volume":"27","author":"Blackstern","year":"1993","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2006.10.020_bib53","first-page":"809","article-title":"SIADH associated with\u00a0fluoxetine and sertraline therapy","volume":"152","author":"Jackson","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib54","first-page":"4395","article-title":"Cardiac effects of antidepressant drugs: a comparison of the tricyclic antidepressants and fluvoxamine","volume":"15","author":"Roose","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2006.10.020_bib55","first-page":"139","article-title":"Bradycardia and syncope induced by fluoxetine","volume":"52","author":"Feder","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(94)91265-3","article-title":"Heart block in a patient on propranolol and fluoxetine","volume":"343","author":"Drake","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2006.10.020_bib57","first-page":"222","article-title":"Adverse consequences of fluoxetine-MAOI combination therapy","volume":"51","author":"Feighner","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib58","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0006-3223(86)90287-8","article-title":"Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five cases reports","volume":"21","author":"Steiner","year":"1986","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","author":"Sternbach","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib60","first-page":"2746","article-title":"Serotonin reuptake inhibitors may increase the risk of osteoporosis","volume":"102","author":"Lerner","year":"2005","journal-title":"Lakartidningen"},{"key":"10.1016\/j.jaad.2006.10.020_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1526-4610.1999.3901028.x","article-title":"Selective serotonin reuptake inhibitors for migraine prophylaxis","volume":"39","author":"Landy","year":"1999","journal-title":"Headache"},{"key":"10.1016\/j.jaad.2006.10.020_bib62","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-2005-916190","article-title":"Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline: a case report","volume":"38","author":"Bickel","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jaad.2006.10.020_bib63","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.EDE.0000050695.99660.D1","article-title":"Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast","volume":"14","author":"Moorman","year":"2003","journal-title":"Epidemiology"},{"key":"10.1016\/j.jaad.2006.10.020_bib64","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/ejso.2000.1066","article-title":"Male breast neoplasia in association with selective serotonin re-uptake inhibitor therapy: a report of three cases","volume":"27","author":"Wallace","year":"2001","journal-title":"Eur J Surg Oncol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206028507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206028507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:05:36Z","timestamp":1759269936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962206028507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0190962206028507"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.10.020","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}